Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. July 20, 2018. Kathie Bardwell.

Executive Summary

Sterilization and decontamination technology firm Steris Corp. had two of its facilities appraised under a voluntary US FDA pilot program that aims to assess device-makers' manufacturing maturity and capability. See what Kathie Bardwell, VP and chief compliance officer for Steris, said about it here.

"In each [appraisal, workers] felt really good that they could talk about what they do for a living, explore things that maybe they know they don’t do really well, or things they have a problem with, and collectively talk about what they might do to improve it." –Kathie Bardwell, VP and chief compliance officer, Steris Corp.

Click here for a free trial of Medtech Insight

Advertisement

Related Content

Boston Scientific, Edwards Lifesciences, Baxter Used CMMI To Measure Their Manufacturing Capability. Here's What They Said About The Experience

Topics

Advertisement
UsernamePublicRestriction

Register

MT122982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel